A phase II study of local therapy only (stereotactic radiosurgery and or surgery) for treatment of up to 5 brain metastases from HER2+ breast cancer
For patients who have HER2 positive breast cancer which has spread to the brain (metastasised) the main treatment options for these brain metastases are as follows: Whole Brain Radiotherapy (WBRT), or Stereotactic Radiosurgery (SRS), or Neurosurgery (NS) This study aims to show that brain metastases are able to be controlled by SRS and/or NS without the need for WBRT.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Accrual Target
25
Closing Date of Accrual
22nd December 2020
Trial Chairperson
Dr Claire Phillips, Peter MacCallum Cancer Centre, VIC
Trial Contact
LocalHero@trog.com.au
Clinical Trial Registration
Related Post
18 October, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
6 September, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
